Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
ICCC — ImmuCell Corporation
NASDAQ
FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

MAY 15, 2026
REVENUE
$10.4M +35.8%
NET MARGIN
18.7% +56.1 PTS
EPS
$0.21 +167.7%
FREE CASH FLOW
$3.4M +994.6%

No summary has been written for this call yet.